APA (7th ed.) Citation

Laribi, K., Bolle, D., Alani, M., Ghnaya, H., Besançon, A., Farhi, J., . . . Materre, A. B. d. Impact of the relative dose intensity on survival of patients with high‐risk myelodysplastic syndromes treated with Azacitidine. Wiley.

Chicago Style (17th ed.) Citation

Laribi, Kamel, Delphine Bolle, Mustafa Alani, Habib Ghnaya, Anne Besançon, Jonathan Farhi, Kayane Mheidly, Nathalie Denizon, and Alix Baugier de Materre. Impact of the Relative Dose Intensity on Survival of Patients with High‐risk Myelodysplastic Syndromes Treated with Azacitidine. Wiley.

MLA (9th ed.) Citation

Laribi, Kamel, et al. Impact of the Relative Dose Intensity on Survival of Patients with High‐risk Myelodysplastic Syndromes Treated with Azacitidine. Wiley.